Colin Suckling, OBE BSc PhD DSc CChem FRSC FRCS(Glasg) Hon FRCS (Edin) FRSA FRSE

Prof

  • United Kingdom

Network

Federica Giordani

  • Wellcome Trust Centre for Molecular Parasitology, University of Glasgow
  • University of Glasgow

External person

Margaret M. Harnett

  • University of Glasgow

External person

Kirsten Gillingwater

  • Swiss Tropical and Public Health Institute
  • Swiss Tropical and Public Health Institute (Swiss TPH)
  • University of Basel

External person

Chun-wa Chung

  • GlaxoSmithKline

External person

Tom Van Agtmael

  • University of Glasgow

External person

Frank Brombacher

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Margaret Harnett

  • University of Glasgow

External person

Rab K. Prinjha

  • Glaxo Smithkline (UK)
  • GlaxoSmithKline

External person

Michael Barrett

  • University of Glasgow

External person

Lerato Hlaka

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Colin Selman

  • University of Glasgow

External person

Ryan J O Nichol

  • University of Strathclyde

External person

Marlene Corbet

  • University of Glasgow
  • University of Glasgow

External person

Reto Guler

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

D. T. Rodgers

  • University of Glasgow

External person

Harry P De Koning

  • University of Glasgow
  • Glasgow University
  • University of Glasgow
  • University of Glasgow

External person

Mumin Ozturk

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

William N. Hunter

  • SULSA (University Administered)

External person

Ryan P. Bingham

  • GlaxoSmithKline

External person

George R. Proctor

  • Strathclyde Institute of Pharmacy and Biomedical Science

External person

Brendan J Fallon

  • GLAXO SMITHKLINE PLC
  • Medicinal Chemistry

External person

Andrew Hobbs

  • GlaxoSmithKline

External person

Laurie Gordon

  • GlaxoSmithKline
  • GlaxoSmithKline

External person

Sandra Duffy

  • Griffith University

External person

Ian Churcher

  • GlaxoSmithKline

External person

Paul S. Carter

  • GlaxoSmithKline

External person

Sarah E. Smith

  • GlaxoSmithKline
  • University of Edinburgh

External person

Peter L. Francis

  • GlaxoSmithKline

External person

Donald O N Somers

  • GlaxoSmithKline

External person

Stephen D. Pickett

  • GlaxoSmithKline

External person

Michael-Jon Rosslee

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Margaret Harnett

  • University of Glasgow

External person

Jane C. Munday

  • Glasgow University

External person

Charlène Fournier

  • GlaxoSmithKline

External person

Philip G. Humphreys

  • Glaxo Smithkline (UK)
  • GlaxoSmithKline
  • GlaxoSmithKline

External person

Jenny Crowe

  • University of Glasgow

External person

Nicolas Ancellin

  • GlaxoSmithKline

External person

Klaus Paulini

  • Department of Pure and Applied Chemistry

External person

Keith E. Suckling

  • Smithkline Beeclmm
  • GlaxoSmithKline

External person

Michael P. Barrett

  • University of Glasgow
  • Glasgow University

External person

M. A. Pineda

  • University of Glasgow

External person

David Rodgers

  • University of Glasgow
  • University of Glasgow

External person

M. M. Harnett

  • University of Glasgow

External person

Kyuji Ohta

  • Department of Pure and Applied Chemistry

External person

Vicky Avery

  • Eskitis Institute, Griffith University, Brisbane, QLD 4111, Australia. t.grkovic@griffith.edu.au.

External person

Nerina Dodic

  • GlaxoSmithKline

External person

Claus Spitzfaden

  • GlaxoSmithKline

External person

Adrian Hernandez Santiago

  • Faculty of Chemistry, Autonomous University of Puebla,

External person

Carl Haslam

  • GlaxoSmithKline

External person

Yoshiaki Washio

  • GlaxoSmithKline

External person

Shao Yang Liu

  • Boston College

External person

Jameed Hussain

  • GlaxoSmithKline

External person

Valentin Bochatay

  • University of Strathclyde

External person

Simon P. Campbell

  • GlaxoSmithKline

External person

Fiona Brown

  • GlaxoSmithKline

External person

Georges Chreifi

  • University of California

External person

Brian Jackson

  • GlaxoSmithKline

External person

Jose J. Marrero-Tellado

  • Department of Pure and Applied Chemistry

External person

Farideh Javid

  • University of Huddersfield

External person

Jessica F. Renaux

  • GlaxoSmithKline

External person

Melanie Leveridge

  • Glaxo Smithkline (UK)
  • GlaxoSmithKline

External person

J. C. Coltherd

  • University of Glasgow

External person

Shu-Li You

  • Shanghai Institute of Organic Chemistry Chinese Academy of Sciences

External person

Edwige Nicodeme

  • GlaxoSmithKline

External person

Gerard Joberty

  • A GSK Company

External person

Inma Rioja

  • GlaxoSmithKline

External person

Ann L. Walker

  • GlaxoSmithKline

External person

Roy Katso

  • GlaxoSmithKline

External person

Olivia J. Robb

  • GlaxoSmithKline

External person

Robert Eagle

  • GlaxoSmithKline

External person

Michael V. Haase

  • GlaxoSmithKline

External person

Simon Allison

  • University of Huddersfield

External person

Joelle Le

  • GlaxoSmithKline
  • Drug Design and Selection - Molecular Design

External person

Giovanni Vitulli

  • GSK, Stevenage
  • Drug Metabolism and Pharmacokinetics

External person

Seble Lemma

  • Medicinal Chemistry

External person

Matthew Campbell

  • Glaxo Smithkline (UK)

External person

Kartheek Sooda

  • University of Huddersfield

External person

Jia Lin Luo

  • Strathclyde Institute of Pharmacy and Biomedical Sciences

External person

Onkar Singh

  • GlaxoSmithKline

External person

David Thomas

  • University of Cambridge

External person

Aneesh Khan

  • University of Glasgow

External person

Omar Hussain

  • University of Huddersfield

External person

Elena Valverde

  • GLAXO SMITHKLINE PLC

External person

Antonia J. Lewis

  • GlaxoSmithKline

External person

Joanna Taylor

  • GlaxoSmithKline

External person

Kenny Herry

  • GlaxoSmithKline

External person

Amy MacDonald

  • Univ Strathclyde

External person

Anne Cooke

  • University of Cambridge

External person

Caroline Dunn

  • Department of Pure and Applied Chemistry

External person

David M. Wilson

  • GlaxoSmithKline

External person

Lamyaa Al-Riyami

  • Strathclyde Institute of Pharmacy and Biomedical Sciences

External person

Leanne Cutler

  • GlaxoSmithKline
  • GlaxoSmithKline

External person

Peter E. Soden

  • GlaxoSmithKline

External person

Gerard Drewes

  • A GSK Company

External person

Soumya Ramu

  • Community for Open Antimicrobial Drug Discovery (CO-ADD), Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia

External person

Huiying Li

  • University of California

External person

Christina Lünse

  • University of Bonn

External person

Susan M. Westaway

  • GlaxoSmithKline

External person

Simon Taylor

  • GlaxoSmithKline
  • GlaxoSmithKline

External person

Grant Reilly

  • Digital Health Institute DHI (SFC Innovation Centre, Administered by the University of Strathclyde

External person

Lee R. Thorp

  • Medicinal Chemistry

External person

Miguel Pineda

  • University of Glasgow

External person

Darren J. Mitchell

  • GlaxoSmithKline

External person

Paul Bamborough

  • GlaxoSmithKline
  • GlaxoSmithKline

External person

Nigel Parr

  • GlaxoSmithKline

External person

Michael D. Barker

  • GlaxoSmithKline
  • LIGO-Hanford Observatory
  • LIGO

External person

Klara Valko

  • GlaxoSmithKline

External person

Benjamin Beaufils

  • GlaxoSmithKline

External person

Günter Mayer

  • University of Bonn

External person

Michelle Coates

  • Strathclyde Institute of Pharmacy and Biomedical Sciences

External person

Niklaas J Buurma

  • University of Cardiff

External person

Paul J. Meakin

  • Ninewells Hospital and Medical School

External person

Matthew H.J. Crawford

  • Medicinal Chemistry

External person

Kevin Lee

  • Takeda Pharmaceuticals

External person

Joanne Edwards

  • University of Glasgow
  • Wolfson Wohl Cancer Research Centre
  • University of Glasgow

External person

Simon J. F. Macdonald

  • Medicinal Chemistry
  • GlaxoSmithKline

External person

Mario Waser

  • Johannes Kepler Universität

External person

Suraj Parihar

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Yumin Dai

  • Virginia Tech

External person

Paul Homes

  • GlaxoSmithKline

External person

Doreen Sekibo

  • Centre for Biological Sciences, Life Science Building, University of Southampton, Southampton SO17 1BJ

External person

Josie Morrell

  • GSK, Stevenage
  • Drug Metabolism and Pharmacokinetics

External person

Ashley P. Hancock

  • Medicinal Chemistry

External person

Mark Taylor

  • University of Toronto, Canada

External person

Michelle H. Wong

  • Cedars-Sinai Medical Center

External person

Angus Lang

  • Department of Pure and Applied Chemistry

External person

Santosh Kumar

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa

External person

Anne-Marie Michon

  • GlaxoSmithKline

External person

John M. Pritchard

  • Medicinal Chemistry

External person

Keri L Barrack

  • University of Dundee, Division of Biological Chemistry and Drug Discovery, College of Life Sciences

External person

Susanne M. Moore

  • GlaxoSmithKline

External person

Kathrin S. Michelsen

  • Cedars-Sinai Medical Center

External person

Richard P. Marshall

  • GlaxoSmithKline

External person

Maxim P Evstigneev

  • Sevastopol National Technical University

External person

Kyo Han Ahn

  • Pohang University of Science and Technology

External person

Eric Boursier

  • GlaxoSmithKline

External person

Nicholas Smithers

  • GlaxoSmithKline

External person

Miguel Pineda

  • University of Glasgow

External person

Roger Phillips

  • University of Huddersfield

External person

Paola Grandi

  • GlaxoSmithKline
  • GlaxoSmithKline GmbH & Co. KG

External person

Santosh Kumar

  • University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa
  • Heriot-Watt University

External person

Graham L. Simpson

  • GlaxoSmithKline

External person

Pamela Thomas

  • GlaxoSmithKline

External person

Sharon G. Bernard

  • GlaxoSmithKline

External person

P.A. Procopiou

  • GlaxoSmithKline
  • Medicinal Chemistry

External person

Laura A. Gummer

  • GlaxoSmithKline

External person

John McElhinney

  • Department of Pure and Applied Chemistry

External person

Tim N. Barrett

  • GlaxoSmithKline
  • Medicinal Chemistry

External person

James R. Gray

  • GlaxoSmithKline

External person

Tracy Shipley

  • GlaxoSmithKline

External person

Miguel Pineda

  • University of Glasgow

External person

Jenny Crowe

  • University of Glasgow

External person

Rino A. Bit

  • Glaxo Smithkline (UK)
  • GlaxoSmithKline

External person

Luis Simon

  • University of Salamanca

External person

Scott McCleary

  • GlaxoSmithKline

External person

Clare I. Hobbs

  • GlaxoSmithKline

External person

Alysha Elliott

  • Community for Open Antimicrobial Drug Discovery (CO-ADD), Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia

External person

Dominic M. Beaumont

  • GlaxoSmithKline

External person

Henry J. Tait

  • University of Strathclyde

External person

Rachel A. Harte

  • University of Newcastle upon Tyne
  • GlaxoSmithKline

External person

Steven L. Sollis

  • Medicinal Chemistry

External person

Neil Garton

  • GlaxoSmithKline

External person

James E. Rowedder

  • GlaxoSmithKline
  • Platform Technology and Science

External person

Jennifer Coltherd

  • University of Glasgow

External person

R. E. Lawrie

  • University of Glasgow

External person

Emmanuel H. Demont

  • GlaxoSmithKline

External person

Jian Zhou

  • East China Normal University

External person

Ian Wall

  • GlaxoSmithKline

External person

Michael L. Ashford

  • Ninewells Hospital and Medical School

External person

K. Fox

  • Rolls Royce PLC

External person

Caterina Vazzana

  • Department of Pure and Applied Chemistry

External person

Paula Duffy

  • University of Strathclyde

External person

Matthew Lindon

  • GlaxoSmithKline
  • GlaxoSmithKline

External person

Stephen Hashmi

  • Universitat Heidelberg

External person

Kate Dennis

  • GlaxoSmithKline

External person

Alex G. S. Preston

  • GlaxoSmithKline

External person

Keith Fox

  • Centre for Biological Sciences, Life Science Building, University of Southampton, Southampton SO17 1BJ
  • Univ Southampton

External person

Thomas L Poulos

  • University of California

External person

Laurie Gordon

  • Glaxo Smithkline (UK)
  • GlaxoSmithKline

External person

Johannes Zuegg

  • Community for Open Antimicrobial Drug Discovery (CO-ADD), Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia

External person

David F. Tough

  • GlaxoSmithKline

External person

Stephen J. Yeaman

  • University of Newcastle upon Tyne

External person

Peter D. Craggs

  • GlaxoSmithKline

External person

Michelle Pemberton

  • GlaxoSmithKline

External person

Lisa A. Sloan

  • GlaxoSmithKline

External person

Hwee Kee Tay

  • University of Glasgow

External person

Iain H. Reid

  • GlaxoSmithKline

External person

Anuradha Tarafdar

  • University of Glasgow

External person

Jack A. Brown

  • GlaxoSmithKline
  • Strathclyde Institute of Pharmacy and Biomedical Science

External person